Dopamine D2 Receptor Blocking Peptide for STJ500708 peptide (STJ503941)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 150-200 on rat Dopamine Receptor D2 protein.
General Information
| Short Description | Dopamine D2 Receptor Blocking Peptide for STJ500708 is synthetically produced from the 150-200 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region 150-200 on rat Dopamine Receptor D2 protein. |
| Immunogen Region | 150-200 |
| Specificity | This blocking peptide is recommended for use in combination with Dopamine D2 Receptor antibody, STJ500708 |
Additional Info
| Background | Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase. |
Information sourced from Uniprot.org